This unit has been discontinued.
.
Introduction
CSA305 Therapeutics in Practice 3A builds upon your existing knowledge of physiology and pharmacology, in order to develop the clinical knowledge and skills necessary to deliver pharmaceutical care.
Topics include the pathophysiology and therapeutics principles used in the management of common diseases. These include cardiovascular, respiratory, renal, and endocrine conditions. An emphasis is placed on the application of knowledge to evaluate and advise upon pharmacotherapy in clinical situations. Skills will be developed for application in the practice setting, including clinical pharmacy skills, pharmaceutical care, patient monitoring (including review of laboratory data) and identification and resolution of drug related problems. Teaching activities will include lectures and tutorials with case studies.
Summary 2020
| Unit name | Therapeutics in Practice 3A |
|---|---|
| Unit code | CSA305 |
| Credit points | 12.5 |
| Faculty/School | College of Health and Medicine School of Pharmacy and Pharmacology |
| Discipline | Pharmacy |
| Coordinator | Mr A Thompson (Coordinator). |
| Teaching staff | Mr M Connolly and Dr T R Zaidi. |
| Level | Advanced |
| Available as student elective? | No |
| Breadth Unit? | No |
Availability
Note
Please check that your computer meets the minimum System Requirements if you are attending via Distance/Off-Campus.
Units are offered in attending mode unless otherwise indicated (that is attendance is required at the campus identified). A unit identified as offered by distance, that is there is no requirement for attendance, is identified with a nominal enrolment campus. A unit offered to both attending students and by distance from the same campus is identified as having both modes of study.
Special approval is required for enrolment into TNE Program units.
TNE Program units special approval requirements.
* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (see withdrawal dates explained for more information).
Fees
Requisites
Prerequisites
CBA221, CJA214, CSA230, CSA231, CSA255, CSA204, CSA225, CSA288
Co-requisites
CSA355
Note for M3I students: CSA231 will be a co-requisite instead of a pre-requisite.
Teaching
| Teaching Pattern | 4 hours of lectures and 2 hours of tutorials weekly throughout semester. |
|---|---|
| Assessment | 1 mid-semester written test (25%), 1 end of semester oral exam (15%) and 1 x 2-hr written exam (60%). On completion of CSA305 students receive an IC (Interim Completion) result. The final result for this unit is granted on completion of CSA306 (Therapeutics in Practice 3B), based on an equal weighting of the marks from the two units CSA305 and CSA306. A student must achieve ≥50% in the end of year (CSA306) written exam plus an overall aggregate mark of ≥50% to pass CSA305 and CSA306. |
| Timetable | View the lecture timetable | View the full unit timetable |
Textbooks
| Required | Information about any textbook requirements will be available from mid November. |
|---|---|
| Recommended |
The University reserves the right to amend or remove courses and unit availabilities, as appropriate.